Position and Enforcement Practice of the People's Republic of China's Pharmaceutical Data Exclusivity Protection

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s104642
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

The Cost-Effectiveness of a NSCLC Patient Assistance Program for Pemetrexed Maintenance Therapy in People's Republic of China

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2017English

Plato's Lysis

2005English

Editor^|^#39;s Note

Seimitsu Kogaku Kaishi/Journal of the Japan Society for Precision Engineering
Mechanical Engineering
2014English

Editor^|^#39;s Note

Seimitsu Kogaku Kaishi/Journal of the Japan Society for Precision Engineering
Mechanical Engineering
2014English

Why Is Dialectical Materialism the People's World Outlook and Methodology of the Communist Party of China?

Journal of Politics and Law
2019English

Editor's Note

Seimitsu Kogaku Kaishi/Journal of the Japan Society for Precision Engineering
Mechanical Engineering
2015English

SANE's Measurement of the Proton's Virtual Photon Spin Asymmetry, Ap1, at Large Bjorken

English

Social Support Received by Multidrug-Resistant Tuberculosis Patients and Related Factors: A Cross-Sectional Study in Zhejiang Province, People's Republic of China

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2016English

Acupuncture and Women's Health: An Overview of the Role of Acupuncture and Its Clinical Management in Women's Reproductive Health

International Journal of Women's Health
GynecologyOncologyMidwiferyMaternityObstetrics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy